Peoples Financial Services Corp’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $149K | Hold |
2,692
| – | – | 0.07% | 149 |
|
|
2025
Q4 | $132K | Hold |
2,692
| – | – | 0.06% | 152 |
|
|
2025
Q3 | $116K | Hold |
2,692
| – | – | 0.05% | 155 |
|
|
2025
Q2 | $103K | Hold |
2,692
| – | – | 0.05% | 154 |
|
|
2025
Q1 | $104K | Sell |
2,692
-160
| -6% | -$5.86K | 0.05% | 154 |
|
|
2024
Q4 | $96.4K | Hold |
2,852
| – | – | 0.04% | 149 |
|
|
2024
Q3 | $117K | Hold |
2,852
| – | – | 0.05% | 142 |
|
|
2024
Q2 | $110K | Hold |
2,852
| – | – | 0.05% | 142 |
|
|
2024
Q1 | $122K | Hold |
2,852
| – | – | 0.05% | 140 |
|
|
2023
Q4 | $106K | Hold |
2,852
| – | – | 0.05% | 145 |
|
|
2023
Q3 | $103K | Sell |
2,852
-320
| -10% | -$11.4K | 0.05% | 148 |
|
|
2023
Q2 | $113K | Sell |
3,172
-1,400
| -31% | -$50.2K | 0.05% | 147 |
|
|
2023
Q1 | $163K | Sell |
4,572
-600
| -12% | -$21K | 0.08% | 139 |
|
|
2022
Q4 | $182K | Sell |
5,172
-400
| -7% | -$13.3K | 0.09% | 139 |
|
|
2022
Q3 | $164K | Sell |
5,572
-605
| -10% | -$22.9K | 0.08% | 137 |
|
|
2022
Q2 | $336K | Hold |
6,177
| – | – | 0.16% | 114 |
|
|
2022
Q1 | $336K | Sell |
6,177
-800
| -11% | -$43.5K | 0.15% | 123 |
|
|
2021
Q4 | $384K | Sell |
6,977
-320
| -4% | -$16.6K | 0.15% | 114 |
|
|
2021
Q3 | $349K | Sell |
7,297
-480
| -6% | -$24.1K | 0.15% | 118 |
|
|
2021
Q2 | $387K | Sell |
7,777
-960
| -11% | -$46.1K | 0.16% | 106 |
|
|
2021
Q1 | $390K | Sell |
8,737
-880
| -9% | -$39.9K | 0.17% | 100 |
|
|
2020
Q4 | $443K | Hold |
9,617
| – | – | 0.2% | 90 |
|
|
2020
Q3 | $453K | Hold |
9,617
| – | – | 0.23% | 85 |
|
|
2020
Q2 | $490K | Buy |
9,617
+45
| +0.5% | +$2.31K | 0.26% | 79 |
|
|
2020
Q1 | $453K | Hold |
9,572
| – | – | 0.27% | 80 |
|
|
2019
Q4 | $562K | Sell |
9,572
-160
| -2% | -$8.9K | 0.27% | 84 |
|
|
2019
Q3 | $519K | Sell |
9,732
-110
| -1% | -$5.66K | 0.26% | 82 |
|
|
2019
Q2 | $492K | Hold |
9,842
| – | – | 0.25% | 83 |
|
|
2019
Q1 | $514K | Hold |
9,842
| – | – | 0.26% | 81 |
|
|
2018
Q4 | $470K | Sell |
9,842
-848
| -8% | -$41.8K | 0.27% | 82 |
|
|
2018
Q3 | $536K | Hold |
10,690
| – | – | 0.27% | 79 |
|
|
2018
Q2 | $539K | Sell |
10,690
-120
| -1% | -$6.04K | 0.3% | 79 |
|
|
2018
Q1 | $527K | Sell |
10,810
-400
| -4% | -$18.6K | 0.3% | 81 |
|
|
2017
Q4 | $497K | Sell |
11,210
-1,760
| -14% | -$81.3K | 0.27% | 82 |
|
|
2017
Q3 | $658K | Sell |
12,970
-240
| -2% | -$12.2K | 0.37% | 70 |
|
|
2017
Q2 | $712K | Sell |
13,210
-240
| -2% | -$12.8K | 0.42% | 70 |
|
|
2017
Q1 | $709K | Sell |
13,450
-3,730
| -22% | -$189K | 0.42% | 68 |
|
|
2016
Q4 | $931K | Sell |
17,180
-30
| -0.2% | -$1.48K | 0.57% | 54 |
|
|
2016
Q3 | $928K | Buy |
17,210
+30
| +0.2% | +$1.65K | 0.58% | 54 |
|
|
2016
Q2 | $931K | Sell |
17,180
-80
| -0.5% | -$4.21K | 0.57% | 54 |
|
|
2016
Q1 | $875K | Buy |
17,260
+4,360
| +34% | +$217K | 0.55% | 52 |
|
|
2015
Q4 | $650K | Sell |
12,900
-400
| -3% | -$20.4K | 0.43% | 65 |
|
|
2015
Q3 | $639K | Sell |
13,300
-40
| -0.3% | -$2.08K | 0.46% | 66 |
|
|
2015
Q2 | $694K | Buy |
13,340
+360
| +3% | +$20.3K | 0.46% | 65 |
|
|
2015
Q1 | $748K | Sell |
12,980
-8
| -0.1% | -$459 | 0.49% | 59 |
|
|
2014
Q4 | $694K | Buy |
12,988
+240
| +2% | +$13.4K | 0.45% | 64 |
|
|
2014
Q3 | $732K | Buy |
12,748
+3,160
| +33% | +$194K | 0.49% | 58 |
|
|
2014
Q2 | $641K | Sell |
9,588
-440
| -4% | -$29.8K | 0.41% | 68 |
|
|
2014
Q1 | $670K | Sell |
10,028
-180
| -2% | -$12.2K | 0.5% | 61 |
|
|
2013
Q4 | $682K | Buy |
+10,208
| New | +$662K | 0.45% | 61 |
|
Other funds holding GSK
JEST
Peoples Financial Services Corp's GSK Position: Q1 2026 in Review
Peoples Financial Services Corp held its GSK (GSK) position steady in Q1 2026 at 2,692 shares worth $149K. The position accounts for 0.07% of the portfolio, ranked #149.
Peoples Financial Services Corp first reported a position in GSK in Q4 2013 and has held it in 50 quarters since. The position peaked at $931K in Q4 2016. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Peoples Financial Services Corp held 2,692 shares of GSK worth $149K as of Q1 2026.
- Peoples Financial Services Corp left its GSK share count unchanged in Q1 2026.
- GSK made up 0.07% of Peoples Financial Services Corp's portfolio in Q1 2026, its #149 holding.
- Peoples Financial Services Corp first reported a position in GSK in Q4 2013 and has held it in 50 quarters since.
- Peoples Financial Services Corp's GSK position peaked at $931K in Q4 2016.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Peoples Financial Services Corp's 13F filing for Q1 2026, filed 20 Apr 2026.